Загрузка...
Ribonuclease-Activated Cancer Prodrug
[Image: see text] Cancer chemotherapeutic agents often have a narrow therapeutic index that challenges the maintenance of a safe and effective dose. Consistent plasma concentrations of a drug can be obtained by using a timed-release prodrug strategy. We reasoned that a ribonucleoside 3′-phosphate co...
Сохранить в:
| Главные авторы: | , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American
Chemical Society
2012
|
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3353771/ https://ncbi.nlm.nih.gov/pubmed/22611478 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/ml2002554 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|